« Back to Record
Citation APA

Postema, P. P., Schwartz, P. P., Arbelo, E., Bannenberg, W. W., Behr, E. R., Belhassen, B., Brugada, J., Brugada, P., Camm, A. J., Casado Arroyo, R., Hoen, E., Hollak, C. C., Kaab, S., Lambiase, P. P., Leenhardt, A., Priori, S. S., Probst, V., Stunnenberg, B. B., Tfelt-Hansen, J., Van Engelen, B. G. M., Veltmann, C., Viskin, S., & Wilde, A. A. M. (2020). Continuedmisuse of orphan drug legislation: A life-threatening risk for mexiletine: orphan drug legislation. European heart journal, 41(5), 614-617. doi:10.1093/eurheartj/ehaa041


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/304985

Postema, P. P., Schwartz, P. P., Arbelo, E., Bannenberg, W. W., Behr, E. R., Belhassen, B., Brugada, J., Brugada, P., Camm, A. J., Casado Arroyo, R., Hoen, E., Hollak, C. C., Kaab, S., Lambiase, P. P., Leenhardt, A., Priori, S. S., Probst, V., Stunnenberg, B. B., Tfelt-Hansen, J., Van Engelen, B. G. M., Veltmann, C., Viskin, S., & Wilde, A. A. M. (2020). Continuedmisuse of orphan drug legislation: A life-threatening risk for mexiletine: orphan drug legislation. European heart journal, 41(5), 614-617. doi:10.1093/eurheartj/ehaa041